Seismic Therapeutic, Inc., the machine learning immunology company, today announced that company management will participate in the following investor conferences:

Guggenheim's Inaugural Healthcare Innovation Conference

Date: Wednesday, November 13, 2024

Location: Boston, MA

Format: Jo Viney, Ph.D., Founder, President and CEO, will be a speaker at the panel presentation titled, “Immunology & Inflammation: Cutting-Edge Technologies Driving the Next Wave of Biotech Breakthroughs”

Stifel Healthcare Conference 2024

Date: Tuesday, November 19, 2024

Location: New York, NY

Format: Company presentation and 1x1 meetings

Jefferies London Healthcare Conference

Date: Tuesday, November 19 – Thursday, November 21, 2024

Location: London, England, UK

Format: 1x1 meetings

Piper Sandler 36^th Annual Healthcare Conference

Date: Wednesday, December 4, 2024

Location: New York, NY

Format: Company presentation and 1x1 meetings

Wells Fargo Virtual Private Biotech Symposium

Date: Thursday, December 12, 2024

Location: Virtual

Format: 1x1 meetings

About Seismic Therapeutic

Seismic Therapeutic™ is a biotechnology company making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241107824833/en/